Comparison of Second-Line Hormonal Agents Medroxyprogesterone Acetate and Aminoglutethimide in Advanced Breast Cancer
Completed
- Conditions
- Breast CancerCancer
- Registration Number
- ISRCTN44725655
- Lead Sponsor
- Ciba-Geigy Pharmaceuticals (Switzerland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Advanced breast cancer
2. Relapsed or failed following tamoxifen treatment
3. Postmenopausal
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration.